ArticleLife (Basel, Switzerland)2025
Short-Term Effects of Capacitive and Resistive Electric Transfer Therapy and Static Splinting in the Management of Trigger Finger: A Non-Randomized Clinical Study.
Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Trigger finger (TF) is a common debilitating hand disorder that often results in pain and functional limitations. Currently accepted conservative treatments include splinting, nonsteroidal anti-inflammatory drugs, and corticosteroid injections. Recently, transfer energy capacitive and resistive (TECAR) therapy is emerging as a promising intervention for its potential to enhance microcirculation, reduce pain and inflammation, and stimulate tissue regeneration in various musculoskeletal conditions. However, its effectiveness for TF remains unclear. This study aims to compare the outcomes between TF conservative management with splinting alone, TECAR therapy alone, and the combined approach. Twenty-one fingers from 16 patients were included, with outcomes measured in terms of pain intensity, Green's TF classification, frequency, severity and functional impact of triggering, and Quick-Disabilities of the Arm, Shoulder, and Hand. Assessments were conducted at baseline, at the fourth and eighth weeks after the initial treatment, and at one-month follow-up. Although all groups showed beneficial effects in all outcomes from baseline to the follow-up, the combined therapy group demonstrated statistically significant, quicker, and higher magnitude improvements in all clinical parameters compared to the single-treatment groups. By combining TECAR therapy with conventional splinting, TF patients may experience faster pain relief and functional recovery. Thus, integrating TECAR therapy into rehabilitation programs may represent a valuable opportunity for enhancing pain management and recovery in TF patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.